Marzieh Amirmostofian

Marzieh Amirmostofian

Auto-generated profile, based on publicly available information

Marzieh Amirmostofian

Mass Spectrometry and Proteomics, College of Health, School of Pharmacy and Biomedical Science Adelaide University Adelaide South Australia Australia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
FAFatima Abid
Fatima Abid
SKSangseo Kim
Sangseo Kim
BSBhumi Savaliya
Bhumi Savaliya
LCLaura Cesari
Laura Cesari
MAMarzieh Amirmostofian
Marzieh Amirmostofian
Sanjay GargSanjay Garg
Sanjay Garg
Purpose: The emergence of antimicrobial resistance (AMR) has made treating acne vulgaris increasingly challenging, thus underscoring the urgent need for new antibacterial therapies. This research aimed to discover, for the first time, the efficacy of monensin (MON) against acne pathogens by encapsulating MON in nanostructured lipid carriers (NLCs) to achieve targeted topical delivery. Methods: MON-loaded NLCs were formulated and optimized using the Design of Experiments (DoE) approach and incorporated in a gel formulation. The potential of MON, MON-NLCs, and its gel formulation was investigated against resistant human isolates of C. acnes, Staphylococcus aureus (S. aureus), and Staphylococcus epidermidis (S. epidermidis) using the agar dilution method. Using the porcine ear skin, the ex vivo deposition of MON was evaluated in different skin layers. The cytotoxicity assay was also performed at antibacterial concentrations using the keratinocyte cell line. Results: MON-loaded NLCs were developed using stearic acid, oleic acid, and Tween® 80 and optimized with particle size, polydispersity index, and zeta potential of 96.65 ± 0.94 nm, 0.13 ± 0.01, and − 36.50 ± 0.30 mV, respectively. The ex vivo deposition experiments showed that MON did not penetrate any skin layer using its water dispersion. However, a significant amount of MON was deposited into the epidermal layer using MON-NLC (4219.86 ± 388.32 ng/cm²) and gel formulation (8180.73 ± 482.37 ng/cm²), whereas no MON permeated to the dermis layer using gel formulation. The antibacterial study revealed the potential of MON, MON-NLC, and gel formulation against C. acnes isolates (MIC range 0.125– 4 μg/mL, 0.25– 4 μg/mL, and 0.125– 1 μg/mL respectively). The cell viability results suggested MON-NLC formulation as a safe topical treatment effective at antibacterial concentrations. Conclusion: This research highlights the novel ability of MON against resistant acne-causing pathogens and the potential of MON-NLCs to deliver MON to the targeted epidermal skin layer effectively.

5 August 2026 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Open access
PDF file
MAMarzieh Amirmostofian
Marzieh Amirmostofian
MWMichael D. Wiese
Michael D. Wiese
PAPaul H. Anderson
Paul H. Anderson
PHPeter Hoffmann
Peter Hoffmann
Rationale: Liquid chromatography–tandem mass spectrometry (LC–MS/MS) analysis of vitamin D 3 metabolites is analytically challenging because these compounds are structurally similar, strongly matrix‐associated, and have poor ionization efficiency. These limitations are particularly important for low‐abundance metabolites such as 1,25(OH) 2 D 3 . This study systematically compared extraction and derivatization strategies to develop a simplified workflow for simultaneous quantification of 25(OH)D 3 , 3‐epi‐25(OH)D 3 , 1,25(OH) 2 D 3 , and 24,25(OH) 2 D 3 in plasma. Methods: Five sample‐preparation approaches—simple protein precipitation, liquid–liquid extraction, salting‐out assisted liquid–liquid extraction, solid‐phase extraction, and supported liquid extraction—were evaluated under comparable conditions. Two derivatization reagents, 4‐(4′‐dimethylaminophenyl)‐1,2,4‐triazoline‐3,5‐dione (DAPTAD) and 2‐fluoro‐1‐methylpyridinium‐ p ‐toluenesulfonate (FMP‐TS), were compared. The selected workflow was validated according to bioanalytical method validation criteria. Results: Supported liquid extraction using ethyl acetate/methyl tert‐butyl ether (1:1, v/v) provided the best overall balance of signal intensity, reproducibility, simplicity, and suitability for high‐throughput processing. DAPTAD derivatization produced a substantially higher MS response than FMP‐TS and was selected for the final method. The optimized SLE‐DAPTAD LC–MS/MS workflow showed good linearity ( r 2 > 0.99), acceptable accuracy and precision, recovery of 72.5%–104%, and limits of quantification of 0.08 ng/mL for 3‐epi‐25(OH)D 3 , 1,25(OH) 2 D 3 , and 24,25(OH) 2 D 3 , and 0.88 ng/mL for 25(OH)D 3 . Conclusions: The optimized SLE‐DAPTAD LC–MS/MS workflow provides a simple, sensitive, and automation‐compatible approach for simultaneous quantification of four vitamin D 3 metabolites in plasma. The method is positioned as an analytical workflow for method development and low‐volume plasma analysis, rather than as a fully standardized routine diagnostic assay for endogenous 1,25(OH) 2 D 3 measurement.